呼吸支持技术在新生儿呼吸窘迫综合征中的应用  

Application of Respiratory Support Technology in Neonatal Respiratory Distress Syndrome

作　　者：江锦 李芳[2] 

机构地区：[1]重庆医科大学附属儿童医院新生儿科,重庆 [2]重庆医科大学附属妇女儿童医院新生儿科,重庆

出　　处：《临床医学进展》2023年第4期6686-6691,共6页Advances in Clinical Medicine

摘　　要：新生儿呼吸窘迫综合征是新生儿尤其是早产儿出生后常见的呼吸系统疾病,也是导致新生儿死亡的重要原因之一。外源性肺泡表面物质联合呼吸机辅助通气是目前公认的针对新生儿呼吸窘迫综合征的核心治疗措施,该措施可以减少病死率及改善晚期预后。本文拟从新生儿呼吸窘迫综合征的病因、肺泡表面活性物质及辅助呼吸技术三个方面着手,对新生儿呼吸窘迫综合征的呼吸支持策略进行综述。Neonatal respiratory distress syndrome (NRDS) is a common respiratory disease in newborns, es-pecially premature infants, and one of the main causes of neonatal death. It is acknowledged that exogenous surfactant therapy combined with ventilation support was the core treatment measure for NRDS and it can reduce the mortality and improve late outcomes. In this paper, respiratory support strategies for neonatal respiratory distress syndrome were reviewed from three aspects: etiology of neonatal respiratory distress syndrome, alveolar surfactant and assisted respiratory techniques.

关 键 词：早产儿 新生儿呼吸窘迫综合征(NRDS) 肺泡表面活性物质(PS) 呼吸支持技术 

分 类 号：R72[医药卫生—儿科]